Prognostic parameter | Univariate analysis | ||
---|---|---|---|
HR | 95% CI | P value | |
Training cohort | Â | Â | Â |
 Age (> 65 vs. ≤ 65) | 1.403 | 0.922–2.135 | 0.114 |
 Gender (male vs. female) | 1.234 | 0.817–1.862 | 0.318 |
 Grade (G3&4 vs. G1&2) | 1.537 | 0.994–2.378 | 0.053 |
 Tumor stage (III + IV vs. I + II) | 0.734 | 0.231–2.329 | 0.600 |
 T classification (T3 + T4 vs. T1 + T2) | 2.194 | 1.131–4.254 | 0.020 |
 Multi-mRNAs-based classifier (high vs. low risk) | 10.119 | 5.134–19.948 | < 0.0001 |